Hans Rommelspacher

AudioCure Pharma GmbH provides preclinical research and clinical development of novel pharmacotherapies to treat disorders of the inner ear. It engages in the clinical development of drug candidates in neurodegenerative disease indications. The firm's offer medicine for the treatment of acute and chronic hearing impairments via local, regenerative therapy of the damaged nerve cells in the inner ear. The company was founded by Hans Rommelspacher in 2010 and is headquartered in Berlin, Germany.

Mount Sinai Hospital is a 431-bed teaching, research and tertiary-care facility. Mount Sinai is a member of Sinai Health System, along with Schwab Rehabilitation Hospital, Sinai Community Institute, Sinai Medical Group and Sinai Children's Hospital.Mount Sinai provides health services to Chicago's West Side Community, as well as to others in the metropolitan area who require sophisticated medical and surgical care. Mount Sinai's medical offerings include a Level I trauma center; a child-abuse diagnosis, treatment and prevention unit; and a high-risk maternity and infant intensive-care program (Level III perinatal center)